What you need to know:
– C signsA developer of AI propelled Cancer detection solutions, announced today a financing round of $ 8 million led by Khosla Ventures.
-The investment will feed the expansion of the United Kingdom company, where it has already had a significant success in the early detection of cancer in the United States.
Cancer screening and improving patient results
C The signs deal with a critical gap in cancer care by identifying patients at risk of cancer at the earliest and most treatable stages. The company’s AI platform analyzes patients’ electronic health files (DSE) to assess the risk of individual cancer, going beyond basic risk factors such as age and sex to examine a wide range of personal and environmental data points. By detecting tumors at previous stages, when they are more likely to be healed, the signs aim to considerably improve cancer survival rates. The company’s AI platform is a precious tool for health care providers, allowing them to provide more proactive and personalized care to their patients.
This personalized approach allows C the signs of:
- Flag of high -risk individuals: Identify patients who need targeted tests and early intervention.
- Reduce unnecessary screening: Exclude patients who are not at high risk, reducing the burden of primary care physicians and health resources.
- Improve early detection rates: Detect cancers earlier, when they are the most treatable, which leads to better results for patients.
Success proven in the United Kingdom
C The signs have shown impressive results within the National Health Service (NHS) of the United Kingdom, where its AI platform A:
- Identified 20.7% of breast cancer cases up to five years earlier that the standard tracks.
- Improvement of the diagnosis of ovarian cancer at an early stage of 53.3% Compared to traditional methods.
“We started c the panels to keep the burden from the identification of the risk of cancer far from the emergency room, when it is often too late. Instead, we want to allow primary care physicians to identify the risk of cancer as soon as possible, in order to considerably increase the risks of survival “,” said C the co-founder of the signs and CEO of Dr Bea Bakshi, MD. “Cancer has a calendar – from the curable to incurable – and the diagnostic time can make the difference between life and loss. We are grateful to Khosla Ventures recognizes the urgency of putting this technology in the hands of more doctors as possible. Together, we work towards a future where each patient has the best possible chances of surviving cancer. »»